News | Artificial Intelligence | October 31, 2019

Zebra Medical Vision Brings AI Solution to Emergent Connect Through New Partnership

The medical imaging analytics company's AI1 (all in one) solution will be available in Emergent's Exceed PACS for all its user base

 Emergent Connect pneumothorax image

The partnership will bring the power of AI to Emergent Connect's growing customer base, leaving zero-footprint on the client side and eliminating the need for on premise installation and local workstation configurations. 

October 31, 2019 — Zebra Medical Vision, a deep learning medical imaging analytics company, announced this week a partnership with Emergent Connect, a leading provider of cloud-based PACS software. The partnership will bring the power of AI to Emergent Connect's growing customer base, leaving zero footprint on the client side and eliminating the need for on premise installation and local workstation configurations.

Emergent Connect manages millions of imaging records per year and helps thousands of healthcare professionals and several hundred clinics provide the best patient care possible. Thanks to this integration, Zebra-Med’s (all in one) AI1 solution will be available in Emergent's Exceed PACS for all its user base, making this one of the largest cloud-first enrollments of clinical, FDA cleared AI to the market so far.

In addition to the zero-footprint PACS, the company’s Exceed RIS customers will also be able to enjoy the benefit of Zebra Medical Vision's Triage solutions running as a safety net for all radiologists on call, flagging the presence of acute conditions on head CTs and chest X-rays.

Helping to cover both outpatient and in-patient settings, Zebra-Med’s Triage solution prioritizes scans based on the emergency level and allows radiologists to address prioritized scans in a timely manner. Scans are forwarded automatically to Zebra-Med’s cloud based solution for analysis, the server then sends an alert of the positive cases directly to the Emergent Connect worklist for prioritizing, thus saving physicians more than 85 percent of the time taken to reach the acute condition, such as a brain bleed in a head CT scan.

Zebra Medical Vision’s AI1 bundle provides hospitals with a growing amount of AI tools and a superior level of service and support. Zebra-Med’s bundle and Emergent Connect’s OEM model allows for seamless integration into their PACS and worklist, and is being offered to all customers with full price transparency per scan.

“We’re honored to take this journey with Emergent Connect, and to offer our services to hundreds of clinics all at once, making this one of the largest enrollments of AI in this market so far,'' said John Logioco, CCO at Zebra Medical Vision. “Our ever growing AI1 portfolio will cover more findings in 2019 and 2020, which will be automatically added to the AI1 bundle and be available to all our clients globally with no additional installations or costs.”

Mike Spears, Emergent Connect’s EVP, Sales & Marketing states, “Zebra-Med’s ever-growing AI1 bundle is a natural choice for integration with our advanced cloud based PACS solution. The innovative ‘zero-footprint’ integration and the quality of AI solutions and service Zebra-Med provides will now be available to our customers, enabling us to transform patient care.”

For more information: https://www.zebra-med.com/

Related Content

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Sponsored Content | Case Study | Artificial Intelligence | April 09, 2020
As the largest independent imaging group in Michigan with 10 locations across the state,...
The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief.

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief. Find more images from the COVID-19 pandemic.

 

Feature | Coronavirus (COVID-19) | April 08, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2  The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ve

 The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ventilators with the need to rapidly triage patients. Contextual detail and considerations for imaging with CXR (chest radiography) versus CT (computed tomography) are presented in the text. (Pos=positive, Neg=negative, Mod=moderate). [Although not covered by this scenario and not shown in the figure, in the presence of significant resources constraints, there is no role for imaging of patients with mild features of COVID-19.] Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | April 07, 2020
April 7, 2020 — A multinational consens...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Children and teenagers with COVID-19...
A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...